ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $219,877 | -92.5% | 1,798 | -92.2% | 0.03% | -92.7% |
Q2 2023 | $2,923,127 | +4.9% | 23,024 | +6.7% | 0.40% | -10.0% |
Q1 2023 | $2,787,789 | +32.2% | 21,584 | +34.4% | 0.44% | +10.8% |
Q4 2022 | $2,109,043 | +13.3% | 16,064 | +0.9% | 0.40% | +16.3% |
Q3 2022 | $1,861,000 | +151.1% | 15,914 | +152.6% | 0.34% | +146.8% |
Q2 2022 | $741,000 | -9.7% | 6,300 | 0.0% | 0.14% | +13.0% |
Q1 2022 | $821,000 | -14.7% | 6,300 | 0.0% | 0.12% | -8.2% |
Q4 2021 | $962,000 | -5.6% | 6,300 | 0.0% | 0.13% | 0.0% |
Q3 2021 | $1,019,000 | -1.2% | 6,300 | 0.0% | 0.13% | +74.0% |
Q2 2021 | $1,031,000 | +8.6% | 6,300 | 0.0% | 0.08% | -37.4% |
Q1 2021 | $949,000 | -0.5% | 6,300 | 0.0% | 0.12% | -17.4% |
Q4 2020 | $954,000 | +11.8% | 6,300 | 0.0% | 0.15% | -1.3% |
Q3 2020 | $853,000 | -0.9% | 6,300 | 0.0% | 0.15% | -14.2% |
Q2 2020 | $861,000 | +8.3% | 6,300 | 0.0% | 0.18% | -12.0% |
Q1 2020 | $795,000 | +4.7% | 6,300 | 0.0% | 0.20% | -8.7% |
Q4 2019 | $759,000 | +21.1% | 6,300 | 0.0% | 0.22% | -6.4% |
Q3 2019 | $627,000 | -23.3% | 6,300 | -16.0% | 0.23% | -16.4% |
Q2 2019 | $818,000 | -2.4% | 7,500 | 0.0% | 0.28% | -6.4% |
Q1 2019 | $838,000 | +11.6% | 7,500 | -3.7% | 0.30% | -10.5% |
Q4 2018 | $751,000 | -20.9% | 7,785 | 0.0% | 0.33% | +7.1% |
Q3 2018 | $949,000 | +11.0% | 7,785 | 0.0% | 0.31% | -11.1% |
Q2 2018 | $855,000 | +6.7% | 7,785 | +3.8% | 0.35% | +49.4% |
Q1 2018 | $801,000 | -19.3% | 7,500 | -19.4% | 0.24% | -26.6% |
Q4 2017 | $993,000 | -9.8% | 9,300 | +181.8% | 0.32% | -28.3% |
Q3 2017 | $1,101,000 | +5.3% | 3,300 | 0.0% | 0.45% | +2.5% |
Q2 2017 | $1,046,000 | +8.8% | 3,300 | 0.0% | 0.44% | +3.6% |
Q1 2017 | $961,000 | +504.4% | 3,300 | +450.0% | 0.42% | +526.9% |
Q4 2016 | $159,000 | -8.6% | 600 | 0.0% | 0.07% | -33.0% |
Q3 2016 | $174,000 | +0.6% | 600 | 0.0% | 0.10% | -8.3% |
Q2 2016 | $173,000 | +121.8% | 600 | +100.0% | 0.11% | +67.7% |
Q1 2016 | $78,000 | – | 300 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |